J Clin Oncol 2024 Jul 24
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).   

Related Questions

Can SRS or whole brain radiotherapy be reserved for progression in these young, healthy patients?